Article citationsMore>>

Health Canada (2025) Guidance on Nitrosamine Impurities in Medications Evaluating and Managing the Risks of N-Nitrosamine Impurities in human Pharmaceutical, Biological and Radiopharmaceutical Products.
https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/nitrosamine-impurities/medications-guidance/guidance-nitrosamine%20impurities-medications.pdf

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top